XHKG
3860
, Last price
HKD
Name
Speed Apparel Holding Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EPS Creative Health Technology Group Limited functions as an investment holding company with diverse operations. It specializes in comprehensive apparel supply chain management, serving clients across Hong Kong, mainland China, Japan, the United States, Europe, and other global markets. The company's activities are divided into two main segments: Garment and Healthcare. Within its Garment division, EPS Creative Health delivers end-to-end supply chain solutions for various knitwear products, including women's, men's, and children's apparel. These services encompass everything from initial fashion trend analysis and product conceptualization to material sourcing, meticulous production oversight, stringent quality control, and efficient logistics. Its clientele primarily comprises owners and sourcing agents of apparel retail brands. Concurrently, the Healthcare segment focuses on the development of novel pharmaceuticals, offers innovative research organization (IRO) services, and provides expert medical consultancy. The group also handles general client account management and related support services. Established in 1999 and headquartered in Hung Hom, Hong Kong, the company was formerly known as Speed Apparel Holding Limited before officially adopting its current name in August 2021. EPS Creative Health Technology Group Limited operates as a subsidiary of EPS Holdings, Inc.
Key people
Wing Kai Chan
Executive Chairman of the Board, Chief Executive Officer, Compliance Officer · since 2016
Ming Ho Ng
Executive Director · since 2016
Yee Kwan Sze
Chief Executive Officer Assistant · since 2004
Lai King Wong
Division Merchandising Manageress
Yu Lim Wu
Chief Financial Officer, Company Secretary · since 2015
Siu Lai Chan
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2017
Kwok Fai Ma
Non-Executive Independent Director · since 2017
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||